cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Adverum Biotechnologies Inc
3 watching
Current Price
$0.69
$0.03
(4.41%)
logo-advm
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
69.24M
52-Week High
52-Week High
1.82
52-Week Low
52-Week Low
0.531
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization69.24M
icon52-Week High1.82
icon52-Week Low0.531
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Adverum Biotechnologies Inc do?
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Read More
How much money does Adverum Biotechnologies Inc make?
News & Events about Adverum Biotechnologies Inc.
Ticker Report
25days ago
Adverum Biotechnologies, Inc. (NASDAQ:ADVM Get Rating) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 2,140,000 shares, a decline of 11.9% from the November 30th total of 2,430,000 shares. ...
Zolmax
26days ago
Adverum Biotechnologies, Inc. (NASDAQ:ADVM Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 2,140,000 shares, a decrease of 11.9% from the November 30th total of 2,430,000 shares. Approximately 2.4% of the ...
Globe Newswire
2 months ago
- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead to stable and persistent aflibercept protein levels through three years in participants in the OPTIC extension study - 81% 98% reduction in mean annualized anti-VEGF injections ...
Zolmax
4 months ago
Adverum Biotechnologies, Inc. (NASDAQ:ADVM Get Rating) CEO Laurent Fischer sold 41,082 shares of the stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $1.07, for a total value of $43,957.74. Following the completion of the sale, the ...
Globe Newswire
4 months ago
REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that data from the OPTIC trial of ixoberogene ...
Frequently Asked Questions
Frequently Asked Questions
What is Adverum Biotechnologies Inc share price today?
plus_minus_icon
Can Indians buy Adverum Biotechnologies Inc shares?
plus_minus_icon
How can I buy Adverum Biotechnologies Inc shares from India?
plus_minus_icon
Can Fractional shares of Adverum Biotechnologies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Adverum Biotechnologies Inc stocks?
plus_minus_icon
What is today’s traded volume of Adverum Biotechnologies Inc?
plus_minus_icon
What is today’s market capitalisation of Adverum Biotechnologies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Adverum Biotechnologies Inc?
plus_minus_icon
What percentage is Adverum Biotechnologies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Adverum Biotechnologies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.69
$0.03
(4.41%)
logo-advm
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00